Iron Gate Global Advisors’s Viking Therapeutics VKTX Stock Holding History

Iron Gate Global Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,980	Closed	-$207K	–	103
2022 Q4	$207K	Sell	21,980 -2,000	-8%	-$8.93K	0.06%	80
2022 Q3	$65K	Hold	23,980	–	–	0.02%	84
2022 Q2	$69K	Hold	23,980	–	–	0.02%	87
2022 Q1	$72K	Hold	23,980	–	–	0.02%	101
2021 Q4	$110K	Hold	23,980	–	–	0.03%	117
2021 Q3	$150K	Hold	23,980	–	–	0.04%	111
2021 Q2	$145K	Buy	+23,980	New	+$142K	0.04%	106
2021 Q1	–	Sell	-19,030	Closed	-$107K	–	106
2020 Q4	$107K	Hold	19,030	–	–	0.04%	90
2020 Q3	$111K	Buy	19,030 +800	+4%	+$5.51K	0.05%	95
2020 Q2	$131K	Sell	18,230 -7,640	-30%	-$50.7K	0.06%	83
2020 Q1	$121K	Hold	25,870	–	–	0.08%	53
2019 Q4	$207K	Hold	25,870	–	–	0.12%	63
2019 Q3	$178K	Hold	25,870	–	–	0.11%	68
2019 Q2	$215K	Hold	25,870	–	–	0.14%	60
2019 Q1	$257K	Hold	25,870	–	–	0.1%	63
2018 Q4	$198K	Sell	25,870 -3,150	-11%	-$37.7K	0.15%	57
2018 Q3	$318K	Buy	29,020 +16,772	+137%	+$200K	0.21%	43
2018 Q2	$116K	Buy	12,248 +200	+2%	+$1.33K	0.09%	59
2018 Q1	$53K	Buy	12,048 +1,270	+12%	+$7.03K	0.04%	53
2017 Q4	$44K	Buy	+10,778	New	+$31.3K	0.04%	49

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Iron Gate Global Advisors's VKTX Position: Q1 2023 in Review

Iron Gate Global Advisors sold out of Viking Therapeutics (VKTX) in Q1 2023, closing a stake of 21,980 shares — an estimated $207K sold.

Iron Gate Global Advisors first reported a position in VKTX in Q4 2017 and held it in 20 quarters. The position peaked at $318K in Q3 2018. 184 funds tracked by Wall St. Rank hold VKTX as of Q1 2023.

Iron Gate Global Advisors reported no remaining Viking Therapeutics position as of Q1 2023 after selling out during the quarter.
Iron Gate Global Advisors sold 21,980 Viking Therapeutics shares in Q1 2023, an estimated $207K.
Iron Gate Global Advisors first reported a position in Viking Therapeutics in Q4 2017 and held it in 20 quarters.
Iron Gate Global Advisors's Viking Therapeutics position peaked at $318K in Q3 2018.
184 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2023.

Based on Iron Gate Global Advisors's 13F filing for Q1 2023, filed 15 May 2023.